Monashee Investment Management LLC Aldeyra Therapeutics, Inc. Transaction History

Monashee Investment Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$7.94 - $11.31 $1.16 Million - $1.66 Million	-146,584 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$10.44 - $14.85 $1.53 Million - $2.18 Million	146,584 New	146,584 $1.66 Million
Q4 2018 Feb 12, 2019	SELL	$7.26 - $13.29 $726,000 - $1.33 Million	-100,000 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$6.8 - $14.35 $680,000 - $1.44 Million	100,000 New	100,000 $1.38 Million
Q4 2017 Feb 09, 2018	SELL	$5.7 - $7.75 $399,000 - $542,500	-70,000 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$3.9 - $10.8 $273,000 - $756,000	70,000	70,000 $504,000

117

36.4M

196K

142K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $280M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monashee Investment Management LLC with notifications on news.